II. Indications
- 
                          Thionamide (Methimazole or Propylthiouracil) Indications- Hyperthyroidism in children and adolescents
- Hyperthyroidism in Pregnancy (first trimester for PTU, Methimazole after)
- Severe Grave's Disease (e.g. Thyroid Storm)
- Subclinical Hyperthyroidism
 
- Methimazole is the preferred first-line Thionamide (over PTU) in most cases due to lower hepatotoxicity
- Reasons to use Propylthiouracil (PTU) instead of Methimazole- Lactation
- Pregnancy (both PTU and Methimazole are Category D)- Use Propylthiouracil (PTU) in first trimester
- Use Methimazole in second and third trimester
 
 
III. Mechanism
IV. Medications
- Propylthiouracil (PTU) 50 mg tablets
V. Dosing: Hyperthyroidism in Adults
- Target dose to Free T4 high end of normal range
- 
                          Hyperthyroidism
                          - Start- Subclinical Hyperthyroidism: 50 to 100 mg orally divided three times daily
- Moderate Hyperthyroidism: 100 to 150 mg orally three times daily
- Severe Hyperthyroidism: 200 to 400 mg orally three times daily
 
- Maintenance- Titrate Propylthiouracil (PTU) dose down after 4 to 6 weeks
- Goal: maintain normal Thyroid function
- Dose: reduce to 50-100 mg/day in divided doses
 
 
- Start
- 
                          Thyroid Storm
                          - See Thyroid Storm for full protocol (Beta Blockers, Thionamides, Iodine, Glucocorticoids)
- Load 500 to 1000 mg PO, PR, or per NG
- Maintenance 200 to 250 mg (up to 400 mg) every 4 hours PO, PR, or per NG
 
VI. Dosing: Hyperthyroidism in Children
- Target dose to Free T4 high end of normal range
- 
                          Hyperthyroidism
                          - Start- Age >10 years old: 50 to 100 mg orally three times daily
- Age 6 to 10 years: 50 mg orally three times daily
- Age <6 years (NOT FDA approved): 5 to 7 mg/kg/day divided every 8 hours
 
- Maintenance- Titrate Propylthiouracil (PTU) dose down after 4 to 6 weeks
- Goal: maintain normal Thyroid function
- Dose: reduce to 1/3 to 1/2 of initial dose
 
 
- Start
VII. Adverse effects (3 per 1000 patients)
- 
                          Drug-Induced Agranulocytosis (more common with PTU)- Risk increases over age 40 years
- Occurs in 0.17% of those on Methimazole
- Presentation: Infection (e.g. Pharyngitis)
- Course- Resolves within 2-3 weeks after drug stopped
- Severe, refractory course may occur
 
- Contraindication to further Antithyroid Drugs
 
- 
                          Jaundice
                          - Cholestatic Jaundice
- Occurs more commonly with Methimazole
 
- Hepatitis- Occurs with both Methimazole and Propylthiouracil (PTU)- However, PTU is higher risk of liver injury, making Methimazole preferred in most cases
 
- Methimazole associated hepatitis- Incidence: 3.17 per 1000 person-years
- Acute Hepatic Failure: 0.32 per 1000 person-years
 
- Propylthiouracil (PTU) is associated with severe liver injury- Adults: 1 in 10,000
- Children: 1 in 2,000
 
 
- Occurs with both Methimazole and Propylthiouracil (PTU)
- Vasculitis
- Lupus-Like Syndrome
- Aplastic Anemia
- Rash or Pruritus- Switch from PTU to Methimazole if severe
 
- Arthralgia or Polyarthritis
- Fever
- Congenital abnormalities possible with Methimazole
VIII. Safety
- 
                          Lactation
                          - PTU is considered safe in Lactation (however Methimazole is preferred over PTU)
 
- Pregnancy Category D (applies to both PTU and Methimazole)- Propylthiouracil is preferred in first trimester (due to congenital defects with Methimazole)
- Use Methimazole instead of PTU in second and third trimester
 
IX. Monitoring
- Repeat examination every 3 months
- Pregnancy Test before starting therapy
- Lab Testing while on antithyroid medications: Monthly for 6 to 12 months- Complete Blood Count (CBC)- Obtain at baseline
- Repeat if Pharyngitis or fever occur (need not be done without symptoms or signs)
 
- Liver Function Tests- Obtain at baseline and if symptoms develop
 
- Thyroid Function Tests (baseline, then every 4-8 weeks, then after stabilizing, every 3 months)- Thyroid Stimulating Hormone (TSH) after stabilizing, once on every 3 month schedule
- Free T4
- Free T3
 
 
- Complete Blood Count (CBC)
- Lab Testing after completing antithyroid medications- Obtain Thyroid Function Tests every 1-3 months for 6-12 months
 
- Indications to discontinue medication (via taper)- Total treatment course of 12-18 months AND
- TSH normalized for 6-12 months
 
- Indications to consider Thyroid ablation- Inadequate suppression at 12 months from initiation
 
X. Efficacy
- Predictors of Relapse on Thionamides (occurs in 30-70% of cases within first year)- Tobacco Abuse
- Large Goiter
- Thyroid Stmulating Antibody high at end of treatment
 
XI. Resources
- Propylthiouracil (DailyMed)
XII. References
Images: Related links to external sites (from Bing)
Related Studies
| propylthiouracil (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| PROPYLTHIOURACIL 50 MG TABLET | Generic | $0.42 each | 
